Takashi Kumazaki

514 citations
39 papers · 415 indexed · h-index 12
Topics
Protein purification and stability (6 papers)Peptidase Inhibition and Analysis (6 papers)Protease and Inhibitor Mechanisms (6 papers)
Partner nations
JapanUnited States

In The Last Decade

Takashi Kumazaki

39 papers receiving 393 citations

Peers

Takashi Kumazaki
Comparison fields: 5 of 73
  • Molecular Biology 295
  • Biotechnology 67
  • Oncology 58
  • Cell Biology 48
  • Genetics 42
Replace Akemi Ikeda with:
Akemi Ikeda Japan
Umberto Ferrini Italy
Richard M. Torczynski United States
A Obrénovitch France
Chi‐Yue Wu Taiwan
Tova Zehavi‐Willner Israel
Raymond A. Vonder Haar United States
Gary McKnight United States
Helga Wessner Germany
Sakae Kitada Japan
Takashi Kumazaki relative to Akemi Ikeda Japan Akemi Ikeda's profile →
Citations per field
00.5×1.7×
Akemi Ikeda · 1×
Citations per year

Countries citing papers authored by Takashi Kumazaki

Since Specialization
Citations

This map shows the geographic impact of Takashi Kumazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Kumazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Kumazaki more than expected).

Fields of papers citing papers by Takashi Kumazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Kumazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Kumazaki. The network helps show where Takashi Kumazaki may publish in the future.

Co-authorship network of co-authors of Takashi Kumazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Kumazaki. A scholar is included among the top collaborators of Takashi Kumazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Kumazaki. Takashi Kumazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 10
3 1
4 9
5 4
6 15
7 8
8 9
9 17
10 39
11 14
12 7
13 21
14 15
15 9
16 6
17 1
18 8
19 28
20 21

About Takashi Kumazaki

Takashi Kumazaki is a scholar working on Biotechnology, Molecular Biology and Cancer Research, having authored 39 papers that have together received 415 indexed citations. Recurring topics across this work include Protein purification and stability (6 papers), Peptidase Inhibition and Analysis (6 papers) and Protease and Inhibitor Mechanisms (6 papers). The work is most often cited by research in Biotechnology (67 citations), Molecular Biology (295 citations) and Cell Biology (48 citations). Takashi Kumazaki has collaborated with scholars based in Japan and United States. Frequent co-authors include Shin‐ichi Ishii, Hideyoshi Yokosawa, Kenta Kajiwara, Fumio Arisaka, Shinzo Nishi, Teruo Ishibashi, Masaharu Sakai, Jun Nishihira, Izumi Nakamura and Kin‐ichiro Miura. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026